Cel-Sci Corporation
CVM
CVM: CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
moreShow CVM Financials
Recent trades of CVM by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CVM's directors and management
Government lobbying spending instances
-
$40,000 Dec 30, 2020 Issue: Medical/Disease Research/Clinical Labs
-
$50,000 Oct 18, 2020 Issue: Medical/Disease Research/Clinical Labs
-
$50,000 Jul 09, 2020 Issue: Medical/Disease Research/Clinical Labs
-
$50,000 Apr 13, 2020 Issue: Medical/Disease Research/Clinical Labs
New patents grants
Federal grants, loans, and purchases
Followers on CVM's company Twitter account
Number of mentions of CVM in WallStreetBets Daily Discussion
Recent insights relating to CVM
Recent picks made for CVM stock on CNBC
ETFs with the largest estimated holdings in CVM
Flights by private jets registered to CVM